It also runs a growing number of clinics and urgent care and surgery centers. UnitedHealth Group Incorporated (NYSE:UNH) has risen 37.57% since July 16, 2017 and is uptrending. This repurchase authorization permits the healthcare conglomerate to buy shares of its stock through open market purchases.
In the second quarter, UnitedHealth added 450,000 more customers to its Medicare Advantage business, which provides privately run versions of the federal government's Medicare program, and another 330,000 to its UnitedHealthcare Community and State business.
UnitedHealth Group Incorporated (NYSE:UNH) belongs to Healthcare sector, except individual factors many other macro and micro factors also effects whole sector and industries.
Castleark Management Llc increased its stake in Unitedhealth Group Inc (UNH) by 18.88% based on its latest 2018Q1 regulatory filing with the SEC. The stock institutional ownership included 87.80% while insider ownership remained 0.50%.
UnitedHealth also reported revenue of $56.09 billion for the second quarter of 2018. Following the completion of the sale, the insider now owns 153,679 shares in the company, valued at $39,118,989.45. Art Ltd Liability Com stated it has 0.07% of its portfolio in UnitedHealth Group Incorporated (NYSE:UNH). As UnitedHealth Group Incorporated has a P/S, P/E and P/B values of 1.18, 25.5 and 5.25 respectively. After beginning the session at $258.29, shares of UnitedHealth Group Incorporated reached as high as $258.45 during the day, while hitting a 1-day low of $256.43.
Optum's revenues grew by 9.1% to $24.7 billion for the quarter with each of Optum's business segments earnings double-digit percentage earnings growth rates. Tracking current stock price levels in relation to some other popular moving averages, we have noted that the stock is trading 4.17% away from the 50-day MA and 2.06% off of the 20-day MA. They expect $3.03 earnings per share, up 23.17 % or $0.57 from last year's $2.46 per share. The business had revenue of $55.19 billion during the quarter, compared to analyst estimates of $54.90 billion. UnitedHealth Group had a return on equity of 19.92% and a net margin of 3.62%. This is up from its revenue of $50.05 billion that was reported in the second quarter of the previous year.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 17th.
Several research analysts have recently commented on the company.
In the recent week UnitedHealth Group Incorporated stock price volatility was noted 1.05% while for the last month volatility was seen at 1.25%. Royal Bank Of Canada lifted their price objective on UnitedHealth Group from $157.00 to $165.00 and gave the company an "outperform" rating in a research note on Wednesday, July 20th. Cantor Fitzgerald maintained UnitedHealth Group Incorporated (NYSE:UNH) rating on Thursday, March 8. Zacks Investment Research upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $287.00 price objective for the company in a research report on Sunday. Captivating a peek at sell-side analyst insights, we can understand that the recent mean target price for the company is $270.71.
In related news, Director Kenneth Irwin Shine sold 325 shares of UnitedHealth Group stock in a transaction on Friday, October 21st. The shares were sold at an average price of $234.20, for a total value of $3,513,000.00. Castleark Management Llc bought 30,284 shares as the company's stock rose 4.65% while stock markets declined. The sale was made public in a document filed with the SEC. The stock was sold at an average price of $254.55 per share, amounting to a transaction worth $5,002,436. The fund acquired 1,555,211 shares of the healthcare conglomerate's stock, valued at approximately $381,555,000. UnitedHealth Group credited the growth to "care delivery and behavioral health, digital consumer engagement and health financial services". It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx.